Skip to main content

Table 2 Two-year outcomes according to gender combination

From: Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood—a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation

 

RI

NRM

LFS

OS

cGVHD

Male to male

22.8 % (15.4–31.1)

36.6 % (28.1–45.1)

40.7 % (31.3–50)

42.4 % (32.8–52)

15.7 % (8.3–25.2)

Female to male

29.2 % (21.1–37.8)

40.8 % (32.3–49.2)

29.9 % (21.3–38.6)

33 % (24.1–41.9)

10.1 % (4.7–18)

Male to female

29 % (21–37.5)

35.1 % (26.7–43.6)

35.9 % (27.1–44.7)

40.9 % (32.1–49.8)

13 % (6.9–21.1)

Female to female

26.3 % (18.9–34.2)

28.4 % (20.4–36.9)

45.3 % (36.5–54.1)

51 % (42.3–59.7)

11.6 % (6.1–19)

P

0.8096

0.098598

0.040965

0.030146

0.83169